Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| SATURNA CAPITAL CORP | 02-06-2024 | 12-31-2023 | 171 | 6,416,583,508 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| CRISPR Therapeutics AG | Common Stock | 151 | $684,218 | 10,930 | 0.00 | 0.00 | 7,197 | 192.79 | 12-31-2023 |
| Telus | Common Stock | 152 | $676,020 | 38,000 | 0.00 | 0.00 | -38,000 | -50.00 | 12-31-2023 |
| Albemarle Corp | Common Stock | Liquidated | $0 | 0 | 0.00 | 0.00 | -1,475 | -32.96 | 12-31-2023 |
| Exponent | Common Stock | 154 | $658,803 | 7,483 | 0.00 | 0.00 | -30 | -0.40 | 12-31-2023 |
